211 related articles for article (PubMed ID: 30930289)
21. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B
Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551
[TBL] [Abstract][Full Text] [Related]
22. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
Haidari M; Ali M; Ward Casscells S; Madjid M
Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
[TBL] [Abstract][Full Text] [Related]
23. Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.
Ma C; Li F; Musharrafieh RG; Wang J
Antiviral Res; 2016 Sep; 133():62-72. PubMed ID: 27478032
[TBL] [Abstract][Full Text] [Related]
24. Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90.
Lamut A; Gjorgjieva M; Naesens L; Liekens S; Lillsunde KE; Tammela P; Kikelj D; Tomašič T
Bioorg Chem; 2020 May; 98():103733. PubMed ID: 32171985
[TBL] [Abstract][Full Text] [Related]
25. Anti-influenza A Virus Activity of Dendrobine and Its Mechanism of Action.
Li R; Liu T; Liu M; Chen F; Liu S; Yang J
J Agric Food Chem; 2017 May; 65(18):3665-3674. PubMed ID: 28417634
[TBL] [Abstract][Full Text] [Related]
26. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
[TBL] [Abstract][Full Text] [Related]
27. Novel Polyanions Inhibiting Replication of Influenza Viruses.
Ciejka J; Milewska A; Wytrwal M; Wojarski J; Golda A; Ochman M; Nowakowska M; Szczubialka K; Pyrc K
Antimicrob Agents Chemother; 2016 Apr; 60(4):1955-66. PubMed ID: 26729490
[TBL] [Abstract][Full Text] [Related]
28. Brevilin A, a Sesquiterpene Lactone, Inhibits the Replication of Influenza A Virus In Vitro and In Vivo.
Zhang X; Xia Y; Yang L; He J; Li Y; Xia C
Viruses; 2019 Sep; 11(9):. PubMed ID: 31500389
[TBL] [Abstract][Full Text] [Related]
29. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
30. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
31. The epidemiology and spread of drug resistant human influenza viruses.
Hurt AC
Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
[No Abstract] [Full Text] [Related]
33. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
34. Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.
Pontoriero A; Baumeister E; Campos AM; Savy VL
Rev Panam Salud Publica; 2011 Dec; 30(6):634-40. PubMed ID: 22358415
[TBL] [Abstract][Full Text] [Related]
35. Influenza virus susceptibility and resistance to oseltamivir.
Aoki FY; Boivin G; Roberts N
Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
[TBL] [Abstract][Full Text] [Related]
36. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
[TBL] [Abstract][Full Text] [Related]
37. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.
Perwitasari O; Johnson S; Yan X; Howerth E; Shacham S; Landesman Y; Baloglu E; McCauley D; Tamir S; Tompkins SM; Tripp RA
J Virol; 2014 Sep; 88(17):10228-43. PubMed ID: 24965445
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.
To KKW; Mok KY; Chan ASF; Cheung NN; Wang P; Lui YM; Chan JFW; Chen H; Chan KH; Kao RYT; Yuen KY
J Gen Virol; 2016 Aug; 97(8):1807-1817. PubMed ID: 27259985
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of 2,4-dichlorophenoxyacetic acid on ROS, autophagy formation, and mRNA replication for influenza virus infection.
Enkhtaivan G; Muthuraman P; Kim DH
J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28233349
[TBL] [Abstract][Full Text] [Related]
40. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
Tilmanis D; van Baalen C; Oh DY; Rossignol JF; Hurt AC
Antiviral Res; 2017 Nov; 147():142-148. PubMed ID: 28986103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
